HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of anaphylaxis with ant venom immunotherapy.

AbstractPURPOSE OF REVIEW:
Worldwide, eight genera of ants have been associated with sting allergy. Until recently only whole ant body extracts have been used for immunotherapy. The purpose of this review is to examine recent advances in the understanding of ant venom allergy and treatment using venom immunotherapy.
RECENT FINDINGS:
Public health problems due to severe ant sting anaphylaxis are not confined to the imported fire ant of North America. Pachycondyla sennaarensis (samsum ant), Pachycondyla chinensis, and Myrmecia pilosula (jack jumper ant) also appear to pose notable threats. The risk to humans from a particular species probably depends on complex interactions between likelihood of human contact, insect aggression, efficiency of the venom delivery apparatus, and venom allergenicity. The highest population prevalence of clinical ant sting allergy so far (3.0%) was reported from south-eastern Australia, due mainly to M. pilosula. Prospective follow-up of untreated people suggests that those older than 30 years with a history of severe reactions (respiratory compromise or hypotension) will benefit most from venom immunotherapy. Whereas the efficacy of ant whole body extract immunotherapy remains to be proven, ant venom immunotherapy has been demonstrated to reduce the risk of systemic reactions to M. pilosula from 72% to 3%. Although a simple method of venom extraction has been developed, small market size means that the treatment may never become widely available.
SUMMARY:
Ant venom immunotherapy is feasible and highly efficacious. However, the limited geographical distribution of each species presents a major challenge to making venom extracts available for clinical use.
AuthorsSimon G A Brown, Robert J Heddle
JournalCurrent opinion in allergy and clinical immunology (Curr Opin Allergy Clin Immunol) Vol. 3 Issue 6 Pg. 511-6 (Dec 2003) ISSN: 1528-4050 [Print] United States
PMID14612677 (Publication Type: Journal Article, Review)
Chemical References
  • Ant Venoms
Topics
  • Anaphylaxis (prevention & control, therapy)
  • Animals
  • Ant Venoms (immunology)
  • Desensitization, Immunologic
  • Humans
  • Insect Bites and Stings (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: